BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 33955288)

  • 1. Short-chain fatty acids-producing probiotics: A novel source of psychobiotics.
    Cheng Y; Liu J; Ling Z
    Crit Rev Food Sci Nutr; 2022; 62(28):7929-7959. PubMed ID: 33955288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Potential of
    De Oliveira FL; Salgaço MK; de Oliveira MT; Mesa V; Sartoratto A; Peregrino AM; Ramos WS; Sivieri K
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional roles of short chain fatty acids as postbiotics in human gut: future perspectives.
    Ragavan ML; Hemalatha S
    Food Sci Biotechnol; 2024 Jan; 33(2):275-285. PubMed ID: 38222911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychobiotics: The Next-Generation Probiotics for the Brain.
    Sharma R; Gupta D; Mehrotra R; Mago P
    Curr Microbiol; 2021 Feb; 78(2):449-463. PubMed ID: 33394083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short chain fatty acids: Microbial metabolites for gut-brain axis signalling.
    O'Riordan KJ; Collins MK; Moloney GM; Knox EG; Aburto MR; Fülling C; Morley SJ; Clarke G; Schellekens H; Cryan JF
    Mol Cell Endocrinol; 2022 Apr; 546():111572. PubMed ID: 35066114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychobiotics: a novel class of psychotropic.
    Dinan TG; Stanton C; Cryan JF
    Biol Psychiatry; 2013 Nov; 74(10):720-6. PubMed ID: 23759244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From isoniazid to psychobiotics: the gut microbiome as a new antidepressant target.
    Butler MI; Sandhu K; Cryan JF; Dinan TG
    Br J Hosp Med (Lond); 2019 Mar; 80(3):139-145. PubMed ID: 30860919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix Effects on the Delivery Efficacy of Bifidobacterium animalis subsp.
    Ba Z; Lee Y; Meng H; Kris-Etherton PM; Rogers CJ; Lewis ZT; Mills DA; Furumoto EJ; Rolon ML; Fleming JA; Roberts RF
    mSphere; 2021 Aug; 6(4):e0008421. PubMed ID: 34232082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota.
    Fusco W; Lorenzo MB; Cintoni M; Porcari S; Rinninella E; Kaitsas F; Lener E; Mele MC; Gasbarrini A; Collado MC; Cammarota G; Ianiro G
    Nutrients; 2023 May; 15(9):. PubMed ID: 37432351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of short-chain fatty acids in microbiota-gut-brain communication.
    Dalile B; Van Oudenhove L; Vervliet B; Verbeke K
    Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):461-478. PubMed ID: 31123355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics and fructo-oligosaccharide intervention modulate the microbiota-gut brain axis to improve autism spectrum reducing also the hyper-serotonergic state and the dopamine metabolism disorder.
    Wang Y; Li N; Yang JJ; Zhao DM; Chen B; Zhang GQ; Chen S; Cao RF; Yu H; Zhao CY; Zhao L; Ge YS; Liu Y; Zhang LH; Hu W; Zhang L; Gai ZT
    Pharmacol Res; 2020 Jul; 157():104784. PubMed ID: 32305492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychobiotics in diet: significance and applications of neuroactive and psychoactive microbial metabolites.
    Giri R; Sharma RK
    Nutr Rev; 2022 Aug; 80(9):2002-2016. PubMed ID: 35352107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From probiotics to psychobiotics - the gut-brain axis in psychiatric disorders.
    Zagórska A; Marcinkowska M; Jamrozik M; Wiśniowska B; Paśko P
    Benef Microbes; 2020 Dec; 11(8):717-732. PubMed ID: 33191776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders.
    Cheng LH; Liu YW; Wu CC; Wang S; Tsai YC
    J Food Drug Anal; 2019 Jul; 27(3):632-648. PubMed ID: 31324280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.
    Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H
    J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Psychobiotics in the Treatment of Psychiatric and Cognitive Disorders: A Systematic Review of Randomized Clinical Trials.
    Mosquera FEC; Lizcano Martinez S; Liscano Y
    Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remodeling of microbiota gut-brain axis using psychobiotics in depression.
    Palepu MSK; Dandekar MP
    Eur J Pharmacol; 2022 Sep; 931():175171. PubMed ID: 35926568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gut microbiota-brain axis, psychobiotics and its influence on brain and behaviour: A systematic review.
    Barrio C; Arias-Sánchez S; Martín-Monzón I
    Psychoneuroendocrinology; 2022 Mar; 137():105640. PubMed ID: 34942539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of probiotic intervention in regulating gut microbiota, short-chain fatty acids and depression-like behavior in lead-exposed rats.
    Chen X; Meng S; Yu Y; Li S; Wu L; Zhang Y
    Int J Occup Med Environ Health; 2022 Feb; 35(1):95-106. PubMed ID: 35143471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Power of Psychobiotics in Depression: A Modern Approach through the Microbiota-Gut-Brain Axis: A Literature Review.
    Dziedzic A; Maciak K; Bliźniewska-Kowalska K; Gałecka M; Kobierecka W; Saluk J
    Nutrients; 2024 Apr; 16(7):. PubMed ID: 38613087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.